In: Accounting
Statement of Cash Flows—Indirect Method
The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as follows:
Dec. 31, 20Y3 | Dec. 31, 20Y2 | ||||
Assets | |||||
Cash | $301,740 | $281,660 | |||
Accounts receivable (net) | 109,310 | 101,160 | |||
Inventories | 308,580 | 299,510 | |||
Investments | 0 | 116,040 | |||
Land | 158,270 | 0 | |||
Equipment | 340,460 | 264,800 | |||
Accumulated depreciation—equipment | (79,710) | (71,410) | |||
Total assets | $1,138,650 | $991,760 | |||
Liabilities and Stockholders' Equity | |||||
Accounts payable (merchandise creditors) | $206,100 | $195,380 | |||
Accrued expenses payable (operating expenses) | 20,500 | 25,790 | |||
Dividends payable | 11,390 | 8,930 | |||
Common stock, $10 par | 61,490 | 48,600 | |||
Paid-in capital: Excess of issue price over par-common stock | 231,150 | 134,880 | |||
Retained earnings | 608,020 | 578,180 | |||
Total liabilities and stockholders’ equity | $1,138,650 | $991,760 |
Additional data obtained from an examination of the accounts in the ledger for 20Y3 are as follows:
Required:
Prepare a statement of cash flows, using the indirect method of presenting cash flows from operating activities. Use the minus sign to indicate cash out flows, cash payments, decreases in cash, or any negative adjustments.
Livers Inc. | ||
Statement of Cash Flows | ||
For the Year Ended December 31, 20Y3 | ||
Cash flows from operating activities: | ||
$ | ||
Adjustments to reconcile net income to net cash flow from operating activities: | ||
Changes in current operating assets and liabilities: | ||
Net cash flow from operating activities | $ | |
Cash flows from investing activities: | ||
$ | ||
Net cash flow used for investing activities | ||
Cash flows from financing activities: | ||
$ | ||
Net cash flow from financing activities | ||
$ | ||
Cash at the beginning of the year | ||
Cash at the end of the year | $ |
Cash Flow Statement (indirect): | |||
Amount $ | |||
Cash from Operating Activities: | |||
Net Income | 76450 | ||
Add:Depreciation | 8300 | ||
Less:Income on Investment sale | -19730 | 135770-116040 | |
less: Inc. in AR | -8150 | 109310-101160 | |
less: Inc. in Inv. | -9070 | 308580-299510 | |
add: Inc. in AP | 10720 | 206100-195380 | |
less: Dec. in Acc Exp. | -5290 | 20500-25790 | |
add: Inc. in DP | 2460 | 11390-8930 | |
Cash Inflow of Operating Activities | 55690 | ||
Cash from Investing Activities: | |||
Add: Sale in Investment | 135770 | ||
Less:Purch. Of equip | -75660 | 340460-264800 | |
Less:Purch. Of land | -158270 | ||
Cash outflow of Investing Activities | -98160 | ||
Cash from Financing Activities: | |||
Add:issue of CS | 12890 | ||
Add: Additional capital received | 96270 | ||
Less:Dividend paid | -46610 | ||
Cash inflow of Financing Activities | 62550 | ||
Net Cash inflow of all activities | 20080 | ||
Add: Opening Cash | 281660 | ||
Closing Cash | 301740 |